Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
12.69
0.71%
After-hours: Aug 15, 2025, 06:19 PM EDT
Cadrenal Therapeutics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Mar 31, 2022 |
Net Income | -14.11M | -12.83M | -10.65M | -7.61M | -6.24M | -4.85M | -8.36M | -12.22M | -12.21M | -11.39M | -6.21M | -1.2M | -176.65K |
Depreciation & Amortization | 6.73K | 6.8K | 1.88K | 2.07K | 2.26K | 2.39K | 1.98K | 2.14K | 2.05K | 1.46K | 1.27K | 506.00 | n/a |
Stock-Based Compensation | 2.2M | 1.81M | 1.42M | 758.95K | 612.04K | 586.72K | 710.38K | 607.27K | 454.19K | 286.4K | n/a | n/a | n/a |
Other Working Capital | 74.89K | -39.61K | 538.1K | 230.98K | 253.36K | 22.88K | 381.89K | 318.75K | 127.35K | 160.49K | 370.86K | 113.78K | 113.78K |
Other Non-Cash Items | 240.13K | 74.94K | 5.7K | 84.41K | -155.66K | 9.62K | 4.05M | 8.24M | 9.27M | 9.27M | 5.3M | 1.03M | 4.05K |
Deferred Income Tax | n/a | n/a | n/a | -78.65K | -78.65K | -78.65K | -78.65K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -10.17K | 611.64K | 1.63M | 345.88K | 934.74K | 303.69K | 144.31K | 152.18K | -102.73K | -13.04K | 482.66K | 128.9K | 128.9K |
Operating Cash Flow | -11.67M | -10.17M | -7.36M | -6.26M | -4.69M | -3.95M | -3.53M | -3.13M | -2.5M | -1.75M | -332.9K | -42.69K | -43.7K |
Capital Expenditures | -6.54K | -9.79K | -6.54K | -3.25K | -3.25K | -3.25K | -3.25K | 2.28K | 2.28K | 2.28K | 2.28K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | 3.25K | 3.25K | 1.00 | 1.00 | -5.53K | -5.53K | -2.28K | -2.28K | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6.54K | -9.79K | -6.54K | n/a | n/a | -3.25K | -3.25K | -3.25K | -3.25K | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 498.54K | 498.54K | 498.54K | 498.54K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.84M | 3.84M | 3.84M | 298.00 | 298.00 | 298.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 12.21M | 10.95M | 8.98M | 1.52M | 6.5M | 6.47M | 11.88M | 12.11M | 5.61M | 6.13M | 725.76K | 506.04K | 506.04K |
Net Cash Flow | 533.56K | 769.65K | 1.62M | -4.75M | 1.81M | 2.54M | 8.37M | 9.01M | 3.17M | 4.43M | 435.28K | 505.78K | 462.34K |
Free Cash Flow | -11.67M | -10.18M | -7.36M | -6.26M | -4.69M | -3.96M | -3.53M | -3.12M | -2.5M | -1.74M | -330.63K | -42.69K | -43.7K |